PD-L1 Tests Market Research Report 2024-2036: Organize your Sales and Marketing Efforts by Identifying Key Market Categories and Segments [Yahoo! Finance]
Agilent Technologies, Inc. (A)
Last agilent technologies, inc. earnings: 2/18 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.agilent.com
Company Research
Source: Yahoo! Finance
Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "PD-L1 Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036" report has been added to ResearchAndMarkets.com's offering. Programmed death ligand-1 (PD-L1) is a protein found on tumor cells. High expression of PD-L1 is linked to more aggressive and fast-growing cancers due to the immune system not being as effective as it should be in attacking cancer cells. PD-L1 interacts with PD-L1 (found on immune T-cells) to deactivate the immune response that would normally occur between cancer cells and T-cells. PD-L1 expression is categorized by no expression (0%), low expression (1-49%) and high expression (50+%). Immunotherapy is most often used when PD-L1 expression is high; however, in some cases where other treatment options fail, immunotherapy medications are used when there is over 1% expression in the tumor sample. Tumors expressing high levels of PD-L1 are candidates for immunotherapy medications to trea
Show less
Read more
Impact Snapshot
Event Time:
A
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
A alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
A alerts
High impacting Agilent Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
A
News
- International Markets and Agilent (A): A Deep Dive for Investors [Yahoo! Finance]Yahoo! Finance
- Oligonucleotides Market Outlook 2034: Projected to Reach US$ 13.1 Billion by 2034, Driven by Expanding Applications in Biotechnology and Precision Medicine | TMR [Yahoo! Finance]Yahoo! Finance
- Mission Bio Partners With Top Researchers From University of Miami to Accelerate Early Relapse Detection & Treatment Selection of Multiple Myeloma Patients [Yahoo! Finance]Yahoo! Finance
- Agilent Technologies: Early Signs Of Turnaround, But Not Cheap Enough [Seeking Alpha]Seeking Alpha
- Cannabis Testing Market to Grow by USD 2.05 Billion (2024-2028), Rising Medical Cannabis Use Boosts Revenue, Report Highlights AI-Driven Market Evolution - Technavio [Yahoo! Finance]Yahoo! Finance
A
Earnings
- 11/25/24 - Beat
A
Sec Filings
- 12/3/24 - Form 4
- 12/2/24 - Form 4
- 12/2/24 - Form 4
- A's page on the SEC website